
Shin Lin Chen
Examiner (ID: 17983, Phone: (571)272-0726 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1633, 1632 |
| Total Applications | 1467 |
| Issued Applications | 727 |
| Pending Applications | 150 |
| Abandoned Applications | 592 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12177304
[patent_doc_number] => 20180036240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'CELL MEMBRANE-DERIVED NANOVESICLES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/545398
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9482
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545398
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545398 | Cell membrane-derived nanovesicles and use thereof | Aug 23, 2015 | Issued |
Array
(
[id] => 11641070
[patent_doc_number] => 09662419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Extracellular matrix encasement structures and methods'
[patent_app_type] => utility
[patent_app_number] => 14/833373
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 7725
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833373
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/833373 | Extracellular matrix encasement structures and methods | Aug 23, 2015 | Issued |
Array
(
[id] => 12286168
[patent_doc_number] => 09932378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Regulators of NFAT
[patent_app_type] => utility
[patent_app_number] => 14/832922
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 43
[patent_no_of_words] => 39770
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832922
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/832922 | Regulators of NFAT | Aug 20, 2015 | Issued |
Array
(
[id] => 11894143
[patent_doc_number] => 09764062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Encapsulation of pancreatic cells derived from human pluripotent stem cells'
[patent_app_type] => utility
[patent_app_number] => 14/820807
[patent_app_country] => US
[patent_app_date] => 2015-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23102
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14820807
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/820807 | Encapsulation of pancreatic cells derived from human pluripotent stem cells | Aug 6, 2015 | Issued |
Array
(
[id] => 10450773
[patent_doc_number] => 20150335787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'Extracellular Matrix Encasement Structures and Methods'
[patent_app_type] => utility
[patent_app_number] => 14/819964
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10061
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14819964
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/819964 | Extracellular Matrix Encasement Structures and Methods | Aug 5, 2015 | Abandoned |
Array
(
[id] => 10450778
[patent_doc_number] => 20150335792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'Extracellular Matrix Encasement Structures and Methods'
[patent_app_type] => utility
[patent_app_number] => 14/818757
[patent_app_country] => US
[patent_app_date] => 2015-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7719
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14818757
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/818757 | Extracellular Matrix Encasement Structures and Methods | Aug 4, 2015 | Abandoned |
Array
(
[id] => 12362457
[patent_doc_number] => 09955677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Non-human animals having a humanized programmed cell death 1 gene
[patent_app_type] => utility
[patent_app_number] => 14/744592
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 8
[patent_no_of_words] => 26854
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14744592
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/744592 | Non-human animals having a humanized programmed cell death 1 gene | Jun 18, 2015 | Issued |
Array
(
[id] => 10797797
[patent_doc_number] => 20160143954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'Isolation and Therapeutic Application of Adult Retinal Stem Cells Collected From Extra-Retinal Tissues'
[patent_app_type] => utility
[patent_app_number] => 14/744549
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10814
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14744549
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/744549 | Isolation and therapeutic application of adult retinal stem cells collected from extra-retinal tissues | Jun 18, 2015 | Issued |
Array
(
[id] => 12362457
[patent_doc_number] => 09955677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Non-human animals having a humanized programmed cell death 1 gene
[patent_app_type] => utility
[patent_app_number] => 14/744592
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 8
[patent_no_of_words] => 26854
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14744592
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/744592 | Non-human animals having a humanized programmed cell death 1 gene | Jun 18, 2015 | Issued |
Array
(
[id] => 12362457
[patent_doc_number] => 09955677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Non-human animals having a humanized programmed cell death 1 gene
[patent_app_type] => utility
[patent_app_number] => 14/744592
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 8
[patent_no_of_words] => 26854
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14744592
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/744592 | Non-human animals having a humanized programmed cell death 1 gene | Jun 18, 2015 | Issued |
Array
(
[id] => 12362457
[patent_doc_number] => 09955677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Non-human animals having a humanized programmed cell death 1 gene
[patent_app_type] => utility
[patent_app_number] => 14/744592
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 8
[patent_no_of_words] => 26854
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14744592
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/744592 | Non-human animals having a humanized programmed cell death 1 gene | Jun 18, 2015 | Issued |
Array
(
[id] => 11619742
[patent_doc_number] => 20170129930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING NEURONAL DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 15/320148
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17202
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320148
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320148 | COMPOSITIONS AND METHODS FOR MODULATING NEURONAL DEGENERATION | Jun 18, 2015 | Abandoned |
Array
(
[id] => 10442512
[patent_doc_number] => 20150327524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO'
[patent_app_type] => utility
[patent_app_number] => 14/715446
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22222
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14715446
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/715446 | Genetically modified non-human animals expressing human EPO | May 17, 2015 | Issued |
Array
(
[id] => 16213931
[patent_doc_number] => 10729723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Method for inducing cell reprogramming, and method for producing pluripotent cells
[patent_app_type] => utility
[patent_app_number] => 15/310189
[patent_app_country] => US
[patent_app_date] => 2015-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 9150
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310189
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310189 | Method for inducing cell reprogramming, and method for producing pluripotent cells | May 10, 2015 | Issued |
Array
(
[id] => 14360643
[patent_doc_number] => 10301609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin
[patent_app_type] => utility
[patent_app_number] => 15/307665
[patent_app_country] => US
[patent_app_date] => 2015-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 13
[patent_no_of_words] => 7262
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15307665
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/307665 | Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin | Apr 28, 2015 | Issued |
Array
(
[id] => 10676694
[patent_doc_number] => 20160022839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/700021
[patent_app_country] => US
[patent_app_date] => 2015-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17571
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14700021
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/700021 | Therapeutic retroviral vectors for gene therapy | Apr 28, 2015 | Issued |
Array
(
[id] => 10721165
[patent_doc_number] => 20160067312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-10
[patent_title] => 'GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL CORD DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/692469
[patent_app_country] => US
[patent_app_date] => 2015-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12652
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14692469
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/692469 | GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL CORD DISORDERS | Apr 20, 2015 | Abandoned |
Array
(
[id] => 11735460
[patent_doc_number] => 09700025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Genetically modified major histocompatibility complex animals'
[patent_app_type] => utility
[patent_app_number] => 14/691175
[patent_app_country] => US
[patent_app_date] => 2015-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 20454
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 356
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14691175
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/691175 | Genetically modified major histocompatibility complex animals | Apr 19, 2015 | Issued |
Array
(
[id] => 14324183
[patent_doc_number] => 10293084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Extracellular matrix (ECM) structures for tissue regeneration
[patent_app_type] => utility
[patent_app_number] => 14/685714
[patent_app_country] => US
[patent_app_date] => 2015-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 12
[patent_no_of_words] => 4068
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14685714
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/685714 | Extracellular matrix (ECM) structures for tissue regeneration | Apr 13, 2015 | Issued |
Array
(
[id] => 10332023
[patent_doc_number] => 20150217027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'Extracellular Matrix Encasement Structures and Methods'
[patent_app_type] => utility
[patent_app_number] => 14/685755
[patent_app_country] => US
[patent_app_date] => 2015-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7725
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14685755
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/685755 | Extracellular matrix encasement structures and methods | Apr 13, 2015 | Issued |